Krane Funds Advisors LLC Purchases New Holdings in Maximus, Inc. (NYSE:MMS)

Krane Funds Advisors LLC purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 5,325 shares of the health services provider's stock, valued at approximately $398,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in MMS. UMB Bank n.a. raised its stake in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank purchased a new stake in Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC lifted its stake in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares in the last quarter. R Squared Ltd purchased a new position in shares of Maximus during the fourth quarter worth $54,000. Finally, IFP Advisors Inc grew its stake in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Maximus Stock Up 1.4 %

Shares of Maximus stock traded up $0.94 during trading hours on Friday, reaching $68.41. 527,898 shares of the company were exchanged, compared to its average volume of 548,296. The firm has a market cap of $3.87 billion, a PE ratio of 14.71 and a beta of 0.68. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The stock's fifty day moving average is $67.90 and its 200 day moving average is $76.15.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.75%. Maximus's dividend payout ratio (DPR) is 25.81%.

Analyst Ratings Changes

MMS has been the topic of several research reports. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Insider Buying and Selling

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.